About us

Who<br>We Are

We Are

Who<br>We Are

About BioGeneric Pharma ​

BioGeneric Pharma S.A.E (BGP) is an international biopharmaceutical company whose principle activities are the development, production and marketing of therapeutic recombinant antibodies ,proteins and vaccines. BGP has constructed a new "State of the art" biopharmaceutical manufacturing facility in the 10th of Ramadan Industrial City, Egypt.


To become the leading biopharmaceutical company, fueled by high technology and quality products and pipeline.​


To provide high quality biopharmaceutical products and vaccines for saving lives​.
BGP Company

CEO Message

I am privileged to lead a company that stands at the forefront of the international biopharmaceutical landscape.

BioGeneric Pharma S.A.E, under our collective vision and unwavering commitment, has become a beacon of excellence in the development and production & marketing of therapeutic recombinant antibodies ,proteins and vaccines.

Professor Dr. Mohamed Rabie Sayed, Msc. FMRC, PhD
President and Chief Executive Officer
BioGeneric Pharma Company

Let’s discuss your project with Our BGP team


Initial Focus on Biosimilars

BGP is focusing on the development and marketing of high quality and cost-effective “off Patent” biosimilars through local manufacturing in BGP’s facility in Egypt targeting EMEA & FDA markets as well as to cover local needs, Africa and Middle East. 

BGP is gradually developing a network of local and regional collaborative partners for sales and marketing of its products. 

The aim is to use this network enabling launch of the product candidates over time. It is critical for BGP to establish partners that have strong local presence and can realize the full sales potential of the respective products in their market. 

Visit from "WHO" Director General
Dr. Tedros Adhanom


Our Expertise

BGP is an international company for development, manufacturing, analysis and marketing of Biopharmaceutical products.